Literature DB >> 25640838

Mitochondrial Ca²⁺ uniporter is critical for store-operated Ca²⁺ entry-dependent breast cancer cell migration.

Shihao Tang1, Xubu Wang2, Qiang Shen3, Xinyi Yang2, Changhui Yu2, Chunqing Cai2, Guoshuai Cai4, Xiaojing Meng5, Fei Zou6.   

Abstract

Metastasis of cancer cells is a complicated multistep process requiring extensive and continuous cytosolic calcium modulation. Mitochondrial Ca(2+) uniporter (MCU), a regulator of mitochondrial Ca(2+) uptake, has been implicated in energy metabolism and various cellular signaling processes. However, whether MCU contributes to cancer cell migration has not been established. Here we examined the expression of MCU mRNA in the Oncomine database and found that MCU is correlated to metastasis and invasive breast cancer. MCU inhibition by ruthenium red (RuR) or MCU silencing by siRNA abolished serum-induced migration in MDA-MB-231 breast cancer cells and reduced serum- or thapsigargin (TG)-induced store-operated Ca2+ entry (SOCE). Serum-induced migrations in MDA-MB-231 cells were blocked by SOCE inhibitors. Our results demonstrate that MCU plays a critical role in breast cancer cell migration by regulating SOCE.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast tumor; MCU; Migration; SOCE

Mesh:

Substances:

Year:  2015        PMID: 25640838     DOI: 10.1016/j.bbrc.2015.01.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

Review 1.  Crosstalk between calcium and reactive oxygen species signaling in cancer.

Authors:  Nadine Hempel; Mohamed Trebak
Journal:  Cell Calcium       Date:  2017-01-18       Impact factor: 6.817

Review 2.  Progress in understanding mitochondrial calcium uniporter complex-mediated calcium signalling: A potential target for cancer treatment.

Authors:  Chaochu Cui; Jianbo Yang; Liwu Fu; Mingyong Wang; Xianwei Wang
Journal:  Br J Pharmacol       Date:  2019-04-03       Impact factor: 8.739

Review 3.  Why don't mice lacking the mitochondrial Ca2+ uniporter experience an energy crisis?

Authors:  Pei Wang; Celia Fernandez-Sanz; Wang Wang; Shey-Shing Sheu
Journal:  J Physiol       Date:  2018-10-11       Impact factor: 5.182

Review 4.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 5.  Mitochondrial calcium uniporter complex modulation in cancerogenesis.

Authors:  Saverio Marchi; Veronica Angela Maria Vitto; Alberto Danese; Mariusz R Wieckowski; Carlotta Giorgi; Paolo Pinton
Journal:  Cell Cycle       Date:  2019-05-10       Impact factor: 4.534

Review 6.  The role of the mitochondrial calcium uniporter (MCU) complex in cancer.

Authors:  Adina Vultur; Christine S Gibhardt; Hedwig Stanisz; Ivan Bogeski
Journal:  Pflugers Arch       Date:  2018-06-21       Impact factor: 3.657

7.  MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.

Authors:  T Ren; H Zhang; J Wang; J Zhu; M Jin; Y Wu; X Guo; L Ji; Q Huang; H Zhang; H Yang; J Xing
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

Review 8.  Mitochondrial Ca2+ signaling.

Authors:  Trayambak Pathak; Mohamed Trebak
Journal:  Pharmacol Ther       Date:  2018-07-20       Impact factor: 12.310

Review 9.  The mitochondrial Ca2+ uniporter: regulation by auxiliary subunits and signal transduction pathways.

Authors:  Bong Sook Jhun; Jyotsna Mishra; Sarah Monaco; Deming Fu; Wenmin Jiang; Shey-Shing Sheu; Jin O-Uchi
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-27       Impact factor: 4.249

10.  Esculetin, a natural coumarin compound, evokes Ca(2+) movement and activation of Ca(2+)-associated mitochondrial apoptotic pathways that involved cell cycle arrest in ZR-75-1 human breast cancer cells.

Authors:  Hong-Tai Chang; Chiang-Ting Chou; You-Sheng Lin; Pochuen Shieh; Daih-Huang Kuo; Chung-Ren Jan; Wei-Zhe Liang
Journal:  Tumour Biol       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.